Impact of Donor Epstein-Barr Virus Serostatus on the Incidence of Graft-Versus-Host Disease in Patients With Acute Leukemia After Hematopoietic Stem-Cell Transplantation: A Study From the Acute Leukemia and Infectious Diseases Working Parties of the European Society for Blood and Marrow Transplantation [Hematologic Malignancy]

Conclusion
Our data suggest that donor EBV status significantly influences development of acute and chronic GVHD after allo-HSCT.

Source: Journal of Clinical Oncology - June 21, 2016 Category: Cancer & Oncology Authors: Styczynski, Tridello, Gil, Ljungman, Hoek, Iacobelli, Ward, Cordonnier, Einsele, Socie, Milpied, Veelken, Chevallier, Yakoub-Agha, Maertens, Blaise, Cornelissen, Michallet, Daguindau, Petersen, Passweg, Greinix, Duarte, Kroger, Dreger, Mohty, Nagler, Cesa Tags: Combined Therapy, Biology & Immunology Hematologic Malignancy Source Type: research